Menu
  • Join
  • Login
  • Contact
 

Search abstracts


RATIONAL DESIGN OF LIVER X RECEPTOR (LXR) MODULATORS USING THE AGONIST GW3965 SCAFFOLD AS A LEAD

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: SHOEMAKE, Claire (University of Malta, Pharmacy, Malta)
  • Co-author(s): Nicole Bonello: Pharmacy, University of Malta, Msida, Malta
    Claire Shoemake: Pharmacy, University of Malta, Msida, Malta
  • Abstract:

    Background

    Pancreatic cancer, probably due to characteristic late diagnosis, is associated with high mortality. The Liver-X_Receptor (LXR) is a druggable target for the development of agonists that could mitigate pancreatic cancer development. Literature indicates that experimental molecules GW3965 and 4-(3-Aryloxyaryl) quinoline sulfone have LXR..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses